Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)

NCT02625610 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

499

Enrollment

INDUSTRY

Sponsor class

Conditions

Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction

Interventions

DRUG: Avelumab
DRUG: Oxaliplatin
DRUG: 5-Fluorouracil
DRUG: Leucovorin
DRUG: Capecitabine
OTHER: Best supportive care
DRUG: Oxaliplatin
DRUG: 5-Fluorouracil
DRUG: Leucovorin
DRUG: Capecitabine

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]